Wang Yanli, Yuan Lulu, Yao Chenjie, Fang Jie, Wu Minghong
J Nanosci Nanotechnol. 2015 Jun;15(6):4143-8. doi: 10.1166/jnn.2015.9792.
Application of nanotechnology and nanomaterials in cancer therapeutics has attracted much attention in recent years. Nano titanium dioxide is one of the most important inorganic functional materials. Cellular toxicity of pH-controlled antitumor drug release system of titanium dioxide nanotubes (TiO2-NTs) in pancreatic cancer cells (SW1990) was evaluated in this paper. The anticancer drug, doxorubicin (DOX) was easily loaded on TiO2-NTs through adsorption forces because of its high specific surface area and perfect surface activity. The drug release from the nanotubes was pH dependent. The toxicological effects were studied after co-incubation of SW1990 with TiO2-NTs-DOX, TiO2-NTs and DOX, respectively. The cellular effect of DOX released from the TiO2-NTs-DOX was same as when DOX was used alone, indicating that the synthesized TiO2-NTs are well qualified as drug carriers in antitumor drug controlled-release system.
近年来,纳米技术和纳米材料在癌症治疗中的应用备受关注。纳米二氧化钛是最重要的无机功能材料之一。本文评估了二氧化钛纳米管(TiO2-NTs)pH 控制的抗肿瘤药物释放系统对胰腺癌细胞(SW1990)的细胞毒性。抗癌药物阿霉素(DOX)因其高比表面积和良好的表面活性,通过吸附力很容易负载在 TiO2-NTs 上。纳米管中的药物释放依赖于 pH。分别将 SW1990 与 TiO2-NTs-DOX、TiO2-NTs 和 DOX 共同孵育后研究其毒理学效应。从 TiO2-NTs-DOX 释放的 DOX 的细胞效应与单独使用 DOX 时相同,表明合成的 TiO2-NTs 在抗肿瘤药物控释系统中完全有资格作为药物载体。